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Background: Diabetes is one of the most widespread chronic disease. Although many medications are available
for the treatment and prevention of diabetes, many people turn to nutritional supplements (NSs). In these years,
the online sales have contributed to the growth of use of nutritional supplement. The aim of the research was to
investigate the type of information provided by sales websites on NSs, and analyse the existence of scientific
evidence about some of the most common ingredients found in available NSs for diabetes.
Methods: A web search was conducted in April 2012 to identify web sites selling NSs in the treatment of diabetes
using Google, Yahoo and Bing! and the key word used was “diabetes nutritional supplements”. Website content
was evaluated for the quality of information available to consumers and for the presence of a complete list of
ingredients in the first NS suggested by the site. Subsequently, in order to analyze the scientific evidence on the
efficacy of these supplements a PubMed search was carried out on the ingredients that were shared in at least 3
nutritional supplements.
Results: A total of 10 websites selling NSs were selected. Only half of the websites had a Food and Drug
Administration disclaimer and 40% declared clearly that the NS offered was not a substitute for proper medication.
A total of 10 NS ingredients were searched for on PubMed. Systematic reviews, meta-analyses or randomized
control trials were present for all the ingredients except one. Most of the studies, however, were of poor quality
and/or the results were conflicting.
Conclusions: Easy internet access to NSs lacking in adequate medical information and strong scientific evidence is
a matter of public health concern, mainly considering that a misleading information could lead to an improper
prevention both in healthy people and people suffering from diabetes. There is a clear need for more trials to
assess the efficacy and safety of these NSs, better quality control of websites, more informed physicians and greater
public awareness of these widely used products.
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Diabetes is one of the most widespread chronic diseases.
According to the World Health Organization (WHO),
the number of people with diabetes rose from 220 million
in 2009 to 346 million in 2011, 90% being diagnosed with
diabetes Type 2 (T2D) [1].
Diabetes, is a disease influenced by lifestyle changes,
such as diet, and so target of complementary and alterna-
tive medicine, including nutritional supplements (NSs) [2].* Correspondence: gelatti@med.unibs.it
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reproduction in any medium, provided the orAs defined by Food and Drug Administration (FDA)
[3], a NS is a product taken by mouth that contains a
“dietary ingredient”, which can be vitamin, mineral, herb,
amino acid, enzyme or metabolite. NSs are generally
offered both to prevent diabetes and support people
with this disease.
NS use has gradually increased in both the United States
(U.S.) [4-6] and Europe [7]. In the U.S. a programme
called NHANES (National Health and Nutrition Exam-
ination Survey) has been developed to monitor the use
of NSs in the population aged 1 year and older. Over
the years, the age-adjusted prevalence of use of NS
increased from 28% and 38% among adult males andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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2003–2006 [6]. In addition, a survey carried out in U.S.
has shown that 73% of the U.S. adult population used
one or more NSs in the year prior the interview and 4%
of them reported an adverse event [5].
In the U.S. the use of NSs is higher in women, the
elderly and people with healthier lifestyles and diets
respect to other persons, but also in persons with chronic
diseases such as diabetes mellitus [8,9]. Another study
found that the use of alternative medicine was significantly
higher among people with diabetes [10]. The European
Community has commissioned the Health and Consumers
Department to monitor the NSs market in Europe. Data
from a recent report [7] shows an increase in the use of
NSs between 1997 and 2005, but with broad variations
from country to country. Market growth in fact ranged
from 20% in the United Kingdom (U.K.) to 219% in
Poland [7].
In recent years, online sales have contributed to the
growth in the use of NSs, and currently an estimated
4% of total NS sales were carried out on internet [11].
Considering the high prevalence of NS use and their
easy access on the internet, the aim of the research was
to investigate the type of information provided by
websites selling NSs on the prevention and treatment
of diabetes. The list of ingredients was also considered
in order to analyse the existence of scientific evidence
regarding their possible effects on diabetes.
Methods
Search strategy
The web search was conducted in April 2012, to identify
websites selling NSs for the treatment and prevention of
diabetes mellitus. The research was performed using 3
of the main search engines commonly used to seek in-
formation, Google, Yahoo and Bing! [12]. The key termFigure 1 Diagram selection of web sites selling diabetes nutritional sused was “diabetes nutritional supplements”. As shown
in Figure 1, the first 30 occurrences on the 3 search en-
gines were analysed to identify websites selling NSs. Sites
were included if (a) they sold supplements directly to
the consumer, (b) they did not require a password to
obtain the ingredients, (c) they showed the complete list
of ingredients and (d) they were in English. Sites were ex-
cluded if they (a) were broken links and (b) were not
organised by disease category. Twenty-eight websites
were identified as sales websites; 12 of these were men-
tioned in more than one search engine and were only
considered once. All the websites identified in Yahoo
were the same identified in Bing!. Six ones didn’t fit the
inclusion criteria. Only 10 sites suited our study
purpose.
Under the “Diabetes” category we analysed the first
nutritional supplement suggested by the website (the
supplements were not shown in alphabetical order).
The content of each website was evaluated according
to the main indications provided by the National Institute
of Health Office of Dietary Supplements (NIH-ODS)
on how to evaluate health information on the internet
[13]. In particular, we evaluated how easy it was to find
the person responsible for the website, the indication of
the health information source and a possible revie-
wer of it, the presence of bibliographical references
supporting the NS, and the presence of the FDA dis-
claimer statement. Testimonials, medical indications,
safety claims and side effects provided by the site were
also recorded.
Literature review
In order to analyse scientific evidence of the efficacy of
these supplements, a PubMed search was carried out on
ingredients shared by at least 3 NSs. The bibliographical
search for the specific ingredient was carried out, inupplements.
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MeSH Database on PubMed: “Diabetes Mellitus” [Mesh].
The search was limited to randomized controlled trials
(RCTs), systematic reviews (SRs) and meta-analyses
(MAs) studies conducted on humans in the last 10 years.
The authoritative fact sheets on NSs provided by the
NIH-ODS and the references reported by the sales
websites in relation to the ingredients selected in this
study were also considered. The FDA website was also
used as a resource.
The literature analysis focused on the findings regarding
the efficacy of these ingredients in treating diabetes
mellitus, the method of administration, the indications
for specific diabetes-related diseases and the possible
side effects.
Results
A total of 10 websites selling NSs for diabetes were
analysed (Table 1). All the websites were located in USA.
In general the NSs were offered to promote healthy
blood sugar levels and reduce the risk of diabetes and
health-related conditions. Half of them suggested contact-
ing a physician about taking NS, two of them only in the
case of pregnancy, breastfeeding or suspected medical
problems. Four websites contained the FDA disclaimer
“This statement has not been evaluated by the FDA. This
product is not intended to diagnose, treat, cure, or prevent
any disease”. On one website the FDA disclaimer was
not complete. The company Xtend-Life stated that the
product on offer was not a substitute for diabetes medi-
cation substitution, but this statement was in the FAQ
section and there was no reference to the FDA. In only
3 out of 10 websites the manufacturer was clearly indi-
cated. (Data not shown in table).
Scientific references supporting the NS offered were
present on 3 websites only. The characteristics of
references retrieved on the three websites are shown
in Table 2. Sixty percent of the websites selected
showed testimonials from customers who had bought
the NS.
We found a total of 71 different ingredients in the 10
NSs selected and some of them were present in more
than one supplement (Figure 2).
A total of 10 NS ingredients were searched for on
PubMed as they were present in at least 3 NSs. All the
ingredients except two (Gymnema sylvestre and Vaccinium
myrtillus) were analysed in RCTs (Figure 2).
In Additional file 1 are shown the characteristics of the
studies investigating the ingredients selected and the main
results. The largest RCT enrolled 447 subjects and
regarded biotin. In the majority of cases (58%), the MA
or SR retrieved only included a few studies (from 2 to
4).The largest study was an SR on chromium that
encompassed 20 separate studies.Reduction in fasting blood glucose, the most commonly
used outcome measure, was statistically significant (p <
0.05) for Gymnema sylvestre and alpha lipoic acid (ALA)
in one of four studies, magnesium in two of three studies,
chromium in four of six studies, zinc in one of four
studies, biotin and Momordica charantia in one of three
studies and Trigonella foenum-graecum in one of two
studies.
Another outcome taken into account was the reduction
in haemoglobin A1c, which was statistically significant
(p < 0.05) for Gymnema sylvestre, magnesium in one of
two studies, chromium picolinate in one of four studies,
zinc in one of two studies, biotin and Trigonella foenum-
graecum in one study and Momordica charantia in one of
two studies.
Adverse effects were rarely considered: in two of four
studies for ALA, one of two studies for Camellia sinensis,
two of three studies for biotin and Momordica charantia
and one of two studies for Trigonella foenum-graecum.
Table 3 shows the dosage of the selected ingredient
indicated in the NS offered by the websites and the
tested dosage from the studies retrieved. For seven out
of ten ingredients the dosage was specified on less than
50% of the websites. The daily dosage indicated for the
NS offered by the websites and the dosage of the relative
ingredient tested were comparable in the case of ALA,
magnesium, chromium and zinc. In the other cases the
dosages were quite different.
Discussion
This study provides an overview of NSs for the preven-
tion and treatment of diabetes available on the internet,
and focuses on the type of information provided by the
websites as well as the scientific evidence supporting
these products.
NSs have gained in popularity in recent years and their
use by the population has increased considerably because
they are readily available and are considered “natural”
substances that can improve or prevent a number of con-
ditions [34]. The internet, as both a source of information
and a marketing tool, has contributed to the easy accessi-
bility of these products [11].
We analysed the content of 10 websites selling NSs for
the treatment and prevention of diabetes, based on some
of the NIH-ODS [13] and FDA indications.
In general, adequate medical information was lacking.
Although NSs do not require FDA approval of their
safety and efficacy, they are products offered to support
people with diabetes and even mitigate the risk of disease-
related complications in addition to prevent diabetes.
For this reason, websites should take particular care when
providing information. It should be noted that potential
users, such as people with a chronic disease, already take
drugs regularly. The risk of drug-NS interactions should
Table 1 Characteristics of nutritional supplements sales websites included in the study





Type II Free http://www.typefreediabetes.com USA-New York Glucocin No No No No
Xtendlife http://www.xtend-life.com USA-Georgia Diabet-Eze Yes No‡ Yes Yes
ADW American Diabetes wholesale http://www.americandiabeteswholesale.com USA-Florida Diachieve Sugar Defense No No Yes Yes
Green Turtle Bay Vitamin Company http://www.energywave.com USA-Winsconsin Diabetiks Yes Yes No Yes
Native Remedies http://www.nativeremedies.com USA-Texas Insulate Plus No No Yes Yes
Heart, Diabetes & Weight Loss http://www.vagnini.com USA-Texas AGE Essential Defence No No No No
NutriVera Naturals http://www.nutrivera.com USA-Minnesota Alpha Betic Yes Yes No No
Optimum Diabetics http://www.optimumdiabetics.com USA-Texas Optimum Diabetics Yes Yes No Yes
Get Healthy Again http://www.gethealthyagain.com USA-Florida Custom Elixir D No No No No
Nutrient Synergy, Inc. http://www.nutrientsynergy.com USA-Florida Nepretin Yes No§ No Yes
*latest access on 20th April 2012 †FDA disclaimer: “This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease” ‡the statement that the product is not a




















Table 2 Characteristics of references retrieved on the












Biotin 19 2 1990
Magnesium 26 2 1998
Chromium 26 10 from 1987 to
2000
Momordica c. 3 1 2007
Gymnema s. 3 - -




† 23 3 1997/1999/2000
Insulate Plus
Chromium 2 1 1990
Gymnema s. 1 - -
Vaccinium m. 2 1 1997
*studies carried out on humans and regarding diabetes, †The studies regarded
the entire product and not the single ingredient.
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tioned the possibility of side effects, and none mentioned
possible interaction with drugs.
Additional concern could arise from the possibility of
counterfeit products available on the Internet. NSs are
less regulated than drugs and therefore more easily subject
to counterfeiting [37]. As stated by FDA the manufacturer
should be easily traced to guarantee transparency of the
product [3]. It is interesting to note the manufacturer was
clearly indicated in only three out of ten NS selected in
this study but one of these one was not found in the list
of manufacturers of the Dietary Supplements Labels
Database [38].
It should be emphasised that NSs are not a substitute
for medical products, but only half of the websites stated
this clearly, four via the FDA disclaimer and one in the
FAQ section. It is interesting to note that when this was
specified, the testimonials could be misleading. For
instance, a company claimed in the FAQ section that
the NS was not a drug substitute, although one customer
reported: “…Today, his blood sugars are more stable… so
much so that the doctor wants him to start weaning him
off of his insulin…”. Another company reported that the
NS is a non-pharmaceutical product, without specifying
that it is not intended to diagnose, cure, mitigate, treat, or
prevent the disease. The testimonials in this website said
such things as “Thank you so much for saving my eyes. I
have not had any surgeries in a long time”, or “My mom’s
advancing eye disease stopped, and slightly reversed, and
her kidney improvement is amazing”. One of the NSsconsidered in this study was cited in a warning letter by
the FDA in 2006 because it was in violation of Federal
Food, Drug and Cosmetic Act [39] regarding a claim that
should not have been included on the website as a testi-
monial “…I had major problems with my feet, and always
felt tingling and discomfort… Since using Insulate Plus this
is a thing of the past…”. This claim still remains, however.
It should be also noted that FDA states that a NS
marker can make no health claims unless approved and
that it is illegal to sell a NS and promote it on its label
or in labelling as a treatment, prevention or cure for a
specific disease or condition [3]. In our opinion some
sentences retrieved in sales websites like “Helps you
prevent and care diabetes” or “helps block diabetes
complications” could be ambiguous.
These are many the reasons why it is necessary to
consult a physician before taking a NS, but only five
websites suggested contacting one, two of them only in
the case of pregnancy, breastfeeding or suspected health
problems.
This message should be presented clearly on the
websites since it has been shown that only a small
percentage of NS users (20-30%) inform their physician
about supplement use [34,40]. Not informing their own
physician, in addition to providing misleading information
on the websites, could lead potential diabetic patients
to stop taking conventional drugs, delay seeking adequate
treatment as they are satisfied with their NS, or reduce
adherence to conventional treatment [41]. Another point
to consider is that potential users, such as patients with
a chronic disease, could take these products for a long
time. As far as we know, however, there is no information
about the long-term effects of using NSs.
The risks for consumers regarding the misleading infor-
mation provided by online companies selling heath related
products direct to the consumer such as drugs [42] or gen-
etic tests [43-45] are widely discussed by previous studies.
In the last years has been spreading the idea that
people, in a view of a better prevention, need to be able
to perform decision-making actions which are beneficial
for the enhancement of their own health [46]. A recent
study showed a great interest in complementary alterna-
tive medicine supplements in patients with diabetes as a
strategy for active engagement in health and disease self-
management [47]. It may be no coincidence that online
companies often influence the formation of a positive
attitude towards their products using the concept of
empowerment. For instance sentences like “…helps you
manage your diabetes…” or “keeping diabetes manage-
ment affordable” found in some websites explain clearly
this concept. However a misleading or not exhaustive
information fails in making people empowered and a
possible consequence is to lead people to a prevention
not completely correct.
Figure 2 Research on PubMed regarding the ingredients of nutritional supplements (NSs). MAs, meta-analyses; NSs, nutritional
supplements; RCTs, randomized control trials; SRs, systematic reviews.
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evaluate the information critically in order to be aware
about their purchase and to use NS appropriately.
One of the NIH-ODS recommendations on how to
evaluate health information on the internet [13] states that
websites should provide medical and scientific evidence
in support of the products presented. Testimonials by
people claiming to have tried a particular product or
service are not evidence-based and usually cannot be
corroborated.
Only three websites provided scientific evidence
supporting the NS offered. Few references actually
concerned the effects on diabetes, however, and themajority of the articles were not recent (before 2002)
(Table 2).
An analysis of literature in the last ten years about the
most widely present ingredients found in NSs offered by
the websites selected showed that scientific evidence is
still lacking. There were RCTs and MAs or SRs for all
but one of the ingredients selected, but the average
number of subjects included in the majority of RCTs is
43 and the average number of studies included in MAs
or SRs is 7. There is therefore a clear lack of large studies,
particular RCTs, and the results are conflicting. These
findings are in agreement with several studies seeking
scientific evidence regarding NSs and diabetes [36,48]
Table 3 Dosage recommended for nutritional supplements (NSs) offered by the companies online and dosage tested
Ingredient N° of websites on which the dosage was
specified/websites selling the relative NS
Dosage per day (mg)




Alpha Lypoic Acid 1/6 600 300 Ansar et al., 2011 [14]
600 de Oliveira, 2011 [15]
600/1200/1800 Bartlett, 2008 [16]
600/1200/1800 Lee, 2011 [17]
Gymnema sylvestre 1/6 2700 400 Leach, 2007 [18]
Magnesium 3/5 300 (2 websites) 365 Mooren, 2011[19]
768 (1 website) 291.6 – 745.2 Bartlett, 2008 [17]
Chromium 2/5 0.3 0.02 – 1 Bartlett, 2008 [16]
0.66 0.04 Sharma, 2011[20]
0.5 Kròl, 2011[21]
0.5 – 1 Ali, 2011[22]
1 Cefalu, 2010 [23]
Zinc 3/4 15 10 Shidfar et al., 2010 [24]
54 30 Bartlett, 2008 [16]
78 50 Hussain, 2006 [25]
Camellia sinensis 2/4 40 150 – 600 Neyestani, 2010 [26]
1800 375 – 750 MacKenzie, 2007 [27]
Biotin 2/3 0.2 2 Albarracin, 2008 [28]
2 Geohas, 2007 [29]
5 Revilla-Monsalve, 2006 [30]
Momordica charantia 1/3 2700 1000 Ooi, 2010 [31]
500-2000 Fuangchan, 2011[32]
Trigonella foenum-graecum 0/3 - 2800 Losso, 2009 [33]
Vaccinium myrtillus 1/3 100 - -
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ment is not yet been established.
It is also interesting to note that the daily dosage of
ingredients present in the NS, where indicated, was not
very comparable to the dosage tested in the studies
retrieved. In some cases the two dosages differed consid-
erably, as in the case of Gymnema sylvestre, Camellia
sinensis, biotin and Momordica charantia.
To our knowledge this is the first study focusing on
NSs for the prevention and treatment of diabetes that
are sold directly to the consumer on the internet. Con-
cerns about the presence on the market of products of
dubious efficacy are compounded with concerns about
the misleading information – or lack of it – on the selling
websites. Another point to underlined is the lack of a
possible mediator, particularly a health professional, in
the purchase of these products.
Some limitations of the study are the low number of
websites retrieved and the fact that they are only in
English. It is also reasonable to assume that this number
will increase, as shown by data regarding use of the
internet as a source of health information [49]. It is alsointeresting to note that a recent report [50] showed
that 53% of American adults age 65 and over use the
internet. This is the very age group affected by chronic
disease. It was also shown that NS use is high among
older people in UK [51]. In our opinion, the possible risks
arising from this scenario that have been discussed in this
study should not be ignored.
Another limitation of this study is that our evaluation
of the scientific evidence in support of NSs only took
into account one ingredient present in more than three
products. It should be noted, however, that it is difficult
to conduct research on NSs because product compos-
ition varies considerably from manufacturer to manu-
facturer, and different products have been studied. The
ingredients are present in combination with other differ-
ent ingredients in the NS and even the dosage varies
greatly. It is therefore necessary to study the efficacy of
NSs on diabetes, not the single ingredients, especially
in the case of products claiming to reduce the risk of a
disease or health-related condition, since potentially
adverse effects and drug interactions cannot be entirely
ruled out.
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In conclusion, easy internet access to NSs lacking ad-
equate medical information and strong scientific evidence
is a public health concern, mainly considering that a mis-
leading information could lead to an improper prevention
especially in healthy people and improper management of
a disease in people suffering from diabetes. It is necessary
to develop appropriate and reliable information to enable
consumers to make an informed decision about the
product prior to purchasing it. Furthermore, health care
providers should be more informed about these widely
used products. It is also evident that more research to
validate the efficacy and safety of these NSs is called for.
Additional file
Additional file 1: Characteristics of references retrieved on the
websites selling nutritional supplements [14-33,52-57].
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